While higher expression of APOL1, ATG4B, ITGA3, WDR45, CASP3, and PRKCD is associated with favorable survival in human bladder cancer patients, increased ULK2 and P4HB mRNA levels are negatively correlated to overall survival of bladder cancer patients. Here, PRKCD is linked to urinary bladder cancer.